Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
accessnewswire.comWellgistics Health Provides Mid-Year 2026 Corporate Outlookaccessnewswire.comJun 1
accessnewswire.comWellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stockaccessnewswire.comMay 28
accessnewswire.comWellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5Maccessnewswire.comMay 27
accessnewswire.comWellgistics Health Completes Reverse Splitaccessnewswire.comMay 26
accessnewswire.comCORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholdersaccessnewswire.comMay 21